Airsculpt Technologies, Inc. (NASDAQ: AIRS)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001870940
Market Cap 134.57 Mn
P/B 1.64
P/E -7.48
P/S 0.85
ROIC (Qtr) -7.30
Div Yield % 0.00
Rev 1y % (Qtr) -17.76
Total Debt (Qtr) 84.21 Mn
Debt/Equity (Qtr) 1.03

About

AirSculpt Technologies, Inc. (AIRS) is a company that operates in the large and growing market for body fat reduction procedures. The company specializes in body contouring treatments, offering a range of minimally invasive procedures to remove unwanted fat and tighten skin. With a growing national footprint of 27 centers across 18 U.S. states, Canada, and the United Kingdom, as of February 27, 2024, AirSculpt is well-positioned to take advantage of the favorable trends driving market growth, including self-image awareness, social acceptance, improved...

Read more

Price action

Investment thesis

Bull case

  • Tangible assets of 66.16M provide exceptional 75.18x coverage of deferred revenue 880000, showing strong service capability backing.
  • Operating cash flow of 8.34M provides strong 9.48x coverage of deferred revenue 880000, indicating service delivery capability.
  • Tangible assets of 66.16M provide robust 7.72x coverage of other current liabilities 8.57M, indicating strong asset backing.
  • Operating cash flow of 8.34M fully covers other non-current liabilities 5.70M by 1.46x, showing strong long-term stability.
  • Cash reserves of 5.41M provide solid 0.95x coverage of other non-current liabilities 5.70M, indicating strong liquidity.

Bear case

  • Operating cash flow of 8.34M barely covers its investment activities of (5.87M), with a coverage ratio of -1.42, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 8.34M provides thin coverage of dividend payments of (238000) with a -35.04 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • The company's operating cash flow of 8.34M shows concerning coverage of stock compensation expenses of 5.96M, with a 1.40 ratio indicating potential earnings quality issues.
  • Operating earnings of (14.68M) show weak coverage of depreciation charges of 12.90M, with a -1.14 ratio indicating high capital intensity and potential reinvestment needs.
  • Operating cash flow of 8.34M provides minimal -2.87x coverage of tax expenses of (2.90M), suggesting potential tax planning inefficiencies or unsustainable tax positions.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.12 1.26
EV to Cash from Ops. EV/CFO 25.01 12.78
EV to Debt EV to Debt 2.48 12.10
EV to EBIT EV/EBIT -14.20 10.74
EV to EBITDA EV/EBITDA -116.92 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 84.58 18.02
EV to Market Cap EV to Market Cap 1.59 432.64
EV to Revenue EV/Rev 1.32 2.77
Price to Book Value [P/B] P/B 1.60 -1.92
Price to Earnings [P/E] P/E -7.31 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) -75.56 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) -2.37 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 52.27 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -9.49 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -184.74 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -111.75 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -494.84 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -975.54 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -107.14 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 106.02 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -20.20 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.85 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.02 0.04
Cash Ratio Cash Ratio (Qtr) 0.22 0.39
Current Ratio Curr Ratio (Qtr) 0.51 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 1.03 -13.19
Interest Cover Ratio Int Coverage (Qtr) -2.37 -97.94
Times Interest Earned Times Interest Earned (Qtr) -2.37 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -1.10 -95.81
EBIT Margin % EBIT Margin % (Qtr) -9.32 -94.97
EBT Margin % EBT Margin % (Qtr) -13.26 -105.60
Gross Margin % Gross Margin % (Qtr) 58.90 23.31
Net Profit Margin % Net Margin % (Qtr) -11.40 -106.14